Diversion Control Homepage Diversion Control Homepage Privacy Policy Contact Us What's New Hot Items Site Map Search Diversion SiteDEA Diversion Control Program Logo and Banner

Federal Register Notices > Notices of Application - 2000 > Applied Sciences Labs

Notices of Application - 2000


[Federal Register: September 6, 2000 (Volume 65, Number 173)]
[Notices]
[Page 54067]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr06se00-92]


DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled Substances; Notice of Application

Pursuant to Section 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on June 13, 2000, Applied Science Labs, Division of Alltech Associates, Inc., 2701 Carolean Industrial Drive, P.O. Box 440, State College, Pennsylvania 16801, made application by renewal to the Drug Enforcement Administration (DEA) for registration as a bulk manufacturer of the basic classes of controlled substances listed below:

Drug  Schedule
Methacathinone (1237) I
N-Ethylamphetamine (1475) I
N,N-Dimethylamphetamine (1480) I
4-Methylaminorex (cis isomer) (1590) I
Lysergic acid diethylamide (7315) I
Mescaline (7381) I
3,4-Methylenedioxyamphetamine (7400) I
N-Hydroxy-3,4-methylenedioxyamphetamine (7402) I
3,4-Methylenedioxy-N-ethylamphetamine (7404) I
3,4-Methylenedioxymethamphetamine (7405)  I
N-Ethyl-1-phenylcyclohexylamine (7455) I
1-(1-Phenylcyclohexyl)pyrrolidine (7458) I
1-[1-(2-Thienyl)cyclohexyl]piperidine (7470) I
Dihydromorphine (9145) I
Normorphine (9313) I
1-Phenylcyclohexylamine (7460) II
Phencyclidine (7471) II
Phenylacetone (8501) II
1-Piperidinocyclohexanecarboni-trile (8603)  II
Cocaine (9041) II
Codeine (9050) II
Dihydrocodeine (9120) II
Benzolyecgonine (9180) II
Morphine (9300) II
Noroxymorphone (9668) II

The firm plans to manufacture small quantities of the listed controlled substances for reference standards.

Any other such applicant and any person who is presently registered with DEA to manufacture such substance may file comments or objections to the issuance of the proposed registration.

Any such comments or objections may be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, United States Department of Justice, Washington, DC 20537, Attention: DEA Federal Register Representative (CCR), and must be filed no later than November 6, 2000.

Dated: August 21, 2000.

John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.

[FR Doc. 00-22683 Filed 9-5-00; 8:45 am]
BILLING CODE 4410-09-M

NOTICE: This is an unofficial version. An official version of these publications may be obtained directly from the Government Printing Office (GPO).

Back to Top


Registration Support  
Toll Free Number: 1-800-882-9539

ARCOS
| Career Opportunities | Chemical Program | Controlled Substance Schedules | Drugs and Chemicals of Concern  
Electronic Commerce Initiatives |  | Federal Register Notices | Import Export | Links | Meetings and Events | NFLIS
Offices & Directories | On-Line Forms & Applications | Program DescriptionPublications | Questions & Answers | Quotas  
  Reports Required by 21 CFR | Title 21 Regulations & Codified CSA
   Contact Us | HomeHot Items | Site Map | Search | What's New